Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-266,179
Closed -$28.9M 891
2025
Q2
$28.9M Buy
266,179
+154,884
+139% +$14.9M 0.08% 215
2025
Q1
$9.22M Sell
111,295
-11,916
-10% -$953K 0.03% 397
2024
Q4
$9.67M Buy
123,211
+18,890
+18% +$1.57M 0.03% 382
2024
Q3
$8.39M Buy
104,321
+52,654
+102% +$4.35M 0.02% 432
2024
Q2
$4.32M Sell
51,667
-21,107
-29% -$1.72M 0.01% 570
2024
Q1
$6.04M Sell
72,774
-1,366
-2% -$112K 0.02% 512
2023
Q4
$5.95M Buy
74,140
+15,447
+26% +$1.07M 0.02% 513
2023
Q3
$3.81M Buy
58,693
+44,781
+322% +$2.98M 0.01% 588
2023
Q2
$907K Sell
13,912
-13,788
-50% -$831K ﹤0.01% 855
2023
Q1
$1.62M Hold
27,700
0.01% 799
2022
Q4
$1.33M Buy
+27,700
New +$1.34M ﹤0.01% 838
2022
Q1
Sell
-45,800
Closed -$2.58M 1236
2021
Q4
$2.58M Buy
45,800
+7,600
+20% +$411K 0.01% 800
2021
Q3
$1.79M Sell
38,200
-17,500
-31% -$829K 0.01% 880
2021
Q2
$2.48M Buy
55,700
+5,300
+11% +$239K 0.01% 852
2021
Q1
$2.16M Buy
50,400
+1,700
+3% +$65.4K 0.01% 837
2020
Q4
$1.58M Buy
+48,700
New +$1.49M 0.01% 900
2020
Q2
Sell
-51,700
Closed -$1.32M 1292
2020
Q1
$1.32M Buy
+51,700
New +$1.49M 0.01% 811
2019
Q2
Sell
-15,000
Closed -$355K 1357
2019
Q1
$355K Buy
+15,000
New +$355K ﹤0.01% 1158
2016
Q3
Sell
-8,100
Closed -$195K 1332
2016
Q2
$195K Buy
8,100
+300
+4% +$7.63K ﹤0.01% 1175
2016
Q1
$199K Sell
7,800
-1,400
-15% -$32.2K ﹤0.01% 1148
2015
Q4
$227K Buy
9,200
+1,100
+14% +$27.5K ﹤0.01% 1161
2015
Q3
$176K Buy
8,100
+2,100
+35% +$53.4K ﹤0.01% 1232
2015
Q2
$175K Buy
6,000
+900
+18% +$24.7K ﹤0.01% 1235
2015
Q1
$122K Buy
5,100
+500
+11% +$12.7K ﹤0.01% 1294
2014
Q4
$127K Buy
4,600
+2,600
+130% +$77.2K ﹤0.01% 1301
2014
Q3
$66K Buy
2,000
+800
+67% +$26K ﹤0.01% 1334
2014
Q2
$37K Sell
1,200
-400
-25% -$12.1K ﹤0.01% 1333
2014
Q1
$49K Sell
1,600
-400
-20% -$12.1K ﹤0.01% 1332
2013
Q4
$62K Buy
2,000
+800
+67% +$24.2K ﹤0.01% 1321
2013
Q3
$31K Buy
+1,200
New +$28.4K ﹤0.01% 1232

Other funds holding STN

Axa's STN Position: Q3 2025 in Review

Axa sold out of Stantec (STN) in Q3 2025, closing a stake of 266,179 shares — an estimated $28.9M sold.

Axa first reported a position in STN in Q3 2013 and held it in 30 quarters. The position peaked at $28.9M in Q2 2025. 280 funds tracked by Wall St. Rank hold STN as of Q3 2025.

  • Axa reported no remaining Stantec position as of Q3 2025 after selling out during the quarter.
  • Axa sold 266,179 Stantec shares in Q3 2025, an estimated $28.9M.
  • Axa first reported a position in Stantec in Q3 2013 and held it in 30 quarters.
  • Axa's Stantec position peaked at $28.9M in Q2 2025.
  • 280 funds tracked by Wall St. Rank held Stantec as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.